Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C-Cure - Safety, Feasibility and Efficacy of Guided Bone Marrow-derived Mesenchymal Cardiopoietic Cells for the Treatment of Heart Failure Secondary to Ischemic Cardiomyopathy

NCT00810238 is registered in ClinicalTrials.gov with Celyad Oncology SA as lead sponsor.

NCT NCT00810238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C-Cure - Safety, Feasibility and Efficacy of Guided Bone Marrow-derived Mesenchymal Cardiopoietic Cells for the Treatment of Heart Failure Secondary to Ischemic Cardiomyopathy
Lead sponsor
Celyad Oncology SA
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2008
Completion date
January 31, 2012
Enrollment
240 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure class ii or iii